News
Investor's Business Daily on MSN
IBD Rating Upgrades: Amkor Technology Shows Improved Price Strength
Amkor Technology AMKR saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 69 ...
Investor's Business Daily on MSN
IBD Rating Upgrades: AtriCure Flashes Improved Price Strength
AtriCure holds the No. 7 rank among its peers in the Medical-Systems/Equipment industry group. Brainsway ADR BWAY, iRadimed ...
Uber's stock drops as investors worry about Lyft and Waymo's partnership impacting the ride-hailing market. Find out more ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe hidradenitis suppurativa (HS).
Stocks bounced around after Federal Reserve Chairman Jerome Powell began his 2:30 p.m. ET press conference. The S&P 500 briefly turned higher but was back down 0.2%. The Dow was up 323 points, or 0.7% ...
Continue reading this article with a Barron’s subscription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results